• Issue

    The Prostate: Volume 81, Issue 11

    711-795
    August 1, 2021
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Page: 711
  • First Published: 28 June 2021

ORIGINAL ARTICLES

Seminal plasma metabolomics reveals lysine and serine dysregulation as unique features distinguishing between prostate cancer tumors of Gleason grades 6 and 7

Oluyemi S. Falegan PhD,  Keith Jarvi MD,  Hans J. Vogel PhD,  M. Eric Hyndman MD, PhD, 
  • Pages: 713-720
  • First Published: 07 June 2021
Open Access

Dynamic multidisciplinary team discussions can improve the prognosis of metastatic castration-resistant prostate cancer patients

Sha Zhu MM,  Junru Chen MM,  Yuchao Ni MB,  Haoran Zhang MD,  Zhenhua Liu MD,  Pengfei Shen MD,  Guangxi Sun MD,  Jiayu Liang MD,  Xingming Zhang MD,  Zhipeng Wang MM,  Qiang Wei MD,  Xiang Li MD,  Ni Chen MD,  Zhiping Li MD,  Xin Wang MD,  Yali Shen MD,  Jin Yao MD,  Rui Huang MD,  Jiyan Liu MD,  Diming Cai MD,  Hao Zeng MD, 
  • Pages: 721-727
  • First Published: 24 May 2021
Open Access

Non-cancer mortality in elderly prostate cancer patients treated with combination of radical prostatectomy and external beam radiation therapy

Mike Wenzel MD,  Christoph Würnschimmel MD,  Francesco Chierigo MD,  Zhe Tian MSc,  Shahrokh F. Shariat MD, PhD,  Carlo Terrone MD, PhD,  Fred Saad MD, PhD,  Derya Tilki MD, PhD,  Markus Graefen MD, PhD,  Philipp Mandel MD, PhD,  Luis A. Kluth MD, PhD,  Felix K. H. Chun MD, PhD,  Pierre I. Karakiewicz MD, PhD, 
  • Pages: 728-735
  • First Published: 19 May 2021

Does surgery benefit patients with oligometastatic or metastatic prostate cancer? – A retrospective cohort study and meta-analysis

Shubin Si MD,  Bin Zheng MD,  Zhenlin Wang MD,  Zhihong Niu MD, PhD, 
  • Pages: 736-744
  • First Published: 31 May 2021
Open Access

Longitudinal measurement of subcutaneous and intratibial human prostate cancer xenograft growth and response to ionizing radiation by plasma Alu and LINE-1 ctDNA: A comparison to standard methods

Alok Mishra,  Kenji Zennami,  Esteban Velarde,  Daniel L. J. Thorek,  Srinivasan Yegnasubramanian,  Theodore L. DeWeese,  Shawn E. Lupold, 
  • Pages: 745-753
  • First Published: 25 May 2021

Barriers and facilitators of germline genetic evaluation for prostate cancer

Stacy Loeb MD, MSc, PhD,  Randall Li MD,  Tatiana Sanchez Nolasco BS,  Nataliya Byrne BA,  Heather H. Cheng MD, PhD,  Daniel Becker MD, MS,  Amy E. Leader DrPH, MPH,  Veda N. Giri MD, 
  • Pages: 754-764
  • First Published: 31 May 2021
Open Access

The role of lymph node dissection in salvage radical prostatectomy for patients with radiation recurrent prostate cancer

Fahad Quhal MD,  Pawel Rajwa MD,  Keiichiro Mori MD,  Ekaterina Laukhtina MD,  Nico C. Grossmann MD,  Victor M. Schuettfort MD,  Frederik König MD,  Abdulmajeed Aydh MD,  Reza S. Motlagh MD,  Satoshi Katayama MD,  Hadi Mostafai MD,  Benjamin Pradere MD,  Giancarlo Marra MD,  Paolo Gontero MD,  Romain Mathieu MD, PhD,  Pierre I. Karakiewicz MD, PhD,  Alberto Briganti MD, PhD,  Shahrokh F. Shariat MD, PhD,  Axel Heidenreich MD, PhD, 
  • Pages: 765-771
  • First Published: 31 May 2021

Clinical characteristics and oncological outcomes in negative multiparametric MRI patients undergoing robot-assisted radical prostatectomy

Vinayak G. Wagaskar MBBS, MCh,  Parita Ratnani MPH, BDS,  Micah Levy,  Kate Moody,  Mariely Garcia,  Adriana M. Pedraza,  Sneha Parekh,  Krunal Pandav,  Bhavya Shukla,  Stanislaw Sobotka PhD, DSc,  Kenneth Haines III MD,  Peter Wiklund MD,  Ash Tewari MBBS, MCh, 
  • Pages: 772-777
  • First Published: 31 May 2021
Open Access

Presence of biopsy Gleason pattern 5 + 3 is associated with higher mortality after radical prostatectomy but not after external beam radiotherapy compared to other Gleason Grade Group IV patterns+

Christoph Würnschimmel MD,  Mike Wenzel MD, BSc,  Francesco Chierigo MD,  Rocco S. Flammia MD,  Keiichiro Mori MD,  Zhe Tian MSc,  Shahrokh F. Shariat MD,  Fred Saad MD,  Alberto Briganti MD,  Nazareno Suardi MD,  Carlo Terrone MD,  Michele Gallucci MD,  Felix K. H. Chun MD,  Derya Tilki MD,  Markus Graefen MD,  Pierre I. Karakiewicz MD, 
  • Pages: 778-784
  • First Published: 31 May 2021
Open Access

Long-term overall survival of radical prostatectomy patients is often superior to the general population: A comparison using life-table data

Christoph Würnschimmel MD,  Mike Wenzel MD, BSc,  Nuowei Wang,  Zhe Tian MSc,  Pierre I. Karakiewicz MD,  Markus Graefen MD,  Hartwig Huland MD,  Derya Tilki MD, 
  • Pages: 785-793
  • First Published: 08 June 2021

LETTER TO THE EDITOR

RE: Wenzel M, et al. The effect of lymph node dissection on cancer-specific survival in salvage radical prostatectomy patients. 2021;1–8

Xiaoxiao Guo,  Jianye Wang, 
  • Page: 794
  • First Published: 25 May 2021

REPLY

Reply to the letter to the editor: RE: Wenzel M, et al. The effect of lymph node dissection on cancer-specific survival in salvage radical prostatectomy patients. The Prostate. 2021;1–8

Mike Wenzel,  Christoph Würnschimmel,  Pierre I. Karakiewicz, 
  • Page: 795
  • First Published: 25 May 2021